ABO-incompatible kidney transplantation

Danish Medical Bulletin

Volumn 57, Issue 10, 2010, Pages

  Schousboe, Karoline ^a   Titlestad, Kjell ^b   Baudier, Francois ^b   Hansen, Lars Ulrich ^b   Bistrup, Claus ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Department of Clinical Immunology ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIBODY; CREATININE; RITUXIMAB; CD20 ANTIGEN; DRUG DERIVATIVE; IMMUNOLOGIC FACTOR; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IMMUNOADSORPTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; MORTALITY; RETROSPECTIVE STUDY; T LYMPHOCYTE; UNIVERSITY HOSPITAL; AGED; BLOOD; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; CHRONIC KIDNEY FAILURE; DENMARK; GRAFT REJECTION; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; BLOOD GROUP INCOMPATIBILITY; CREATININE; DENMARK; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES; TACROLIMUS;

EID: 79251482760     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. The Danish Society of Nephrology. Danish Nephrology Registry, Annual Report. 2006.
2. Meier-Kriesche HU, Port FK, Ojo AO et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000;58:1311-7.
3. www.scandiatransplant.org. (1 May 2010).
4. The Danish Society of Nephrology. Danish Nephrology Registry, Annual Report. 2008.
5. Linnet J and Brennum J. Dobbelt livreddende behandling. Ugeskr Læger 2009;13:1112-3.
6. Cecka JM. The OPTN/UNOS Renal Transplant Registry. Clin Transpl 2005;1-16.
7. Kumlien G, Ullstrom L, Losvall A et al. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006;46:1568-75.
8. Rydberg L. ABO-incompatibility in solid organ transplantation. Transfus Med 2001;11:325-42.
9. Tyden G, Kumlien G, Fehrman I. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003;76:730-1.
10. Just SA, Marcussen N, Sprogoe U et al. Acute antibody-mediated rejection after ABO-incompatible kidney transplantation treated successfully with antigen-specific immunoadsorption. Nephrol Dial Transplant 2010;25:310-13.
11. Donauer J, Wilpert J, Geyer M et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a single center experience. Xenotransplantation 2006;13:108-10.
12. Shimmura H, Tanabe K, Ishikawa N et al. Role of anti-A/B antibody titers in results of ABO-incompatible kidney transplantation. Transplantation 2000;70:1331-5.
13. Tyden G, Kumlien G, Genberg H et al. The Stockholm experience with ABOincompatible kidney transplantations without splenectomy. Xenotransplantation 2006;13:105-7.
14. Kumlien G, Wilpert J, Safwenberg J et al. Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers. Transplantation 2007;84:S17-S19.
15. Aalten J, Hoogeveen EK, Roodnat JI et al. Associations between prekidney- transplant risk factors and post-transplant cardiovascular events and death. Transpl Int 2008;21:985-91.
16. Genberg H, Kumlien G, Wennberg L et al. Long-term results of ABOincompatible kidney transplantation with antigen-specific immunoadsorption and rituximab. Transplantation 2007;84:S44-S47.
17. Geyer M, Donauer J, Pisarski P et al. Preemptive postoperative antigenspecific immunoadsorption in ABO-incompatible kidney transplantation: necessary or not? Transplantation 2007;84:S40-S43.
18. Birkeland SA, Elbirk A, Rohr N et al. Optimization of cyclosporine monotherapy--long-term graft function. Transplant Proc 1994;26:2501-6.
19. Galliford J, Charif R, Chan KK et al. ABO incompatible living renal transplantation with a steroid sparing protocol. Transplantation 2008;86:901-6.
20. Oettl T, Zuliani E, Gaspert A et al. Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejection. Transplantation 2010;89:702-6.